经尿道前列腺棒状水囊扩裂术在良性前列腺增生治疗中的疗效分析  

The Clinical Efficacy and Safety of Transurethral Rod Hydrosalping of the Prostate in the Treatment of Benign Prostatic Hyperplasia

作　　者：宫再兴 徐庆刚[1] GONG Zaixing;XU Qinggang(Department of Urology,the Hospital Jiangxi University of Traditional Chinese Medicine,Nanchang City,Jiangxi Province 330000)

机构地区：[1]江西中医药大学附属医院泌尿外科,江西省南昌市330000

出　　处：《医学理论与实践》2023年第1期24-27,30,共5页The Journal of Medical Theory and Practice

基　　金：江西省卫健委科技计划(20195336)。

摘　　要：目的:探讨经尿道前列腺棒状水囊扩裂术治疗良性前列腺增生的临床疗效和安全性。方法:选取2019年1月-2020年12月我院收治的46例前列腺增生患者,按随机数字法分为观察组与对照组,每组23例,观察组采用经尿道前列腺棒状水囊扩裂术治疗,对照组采用经尿道前列腺等离子电切术治疗,记录并比对两组患者的手术前后观察指标、恢复指标、术后并发症情况。结果:两组患者术后3个月的残余尿量、最大尿流率、国际前列腺症状IPSS评分、生活质量QoL评分的差异无统计学意义(P>0.05)。与对照组相比,观察组患者在手术时间、术中出血量、术后拔管时间、术后3个月性功能(IIEF5)评分、尿道狭窄和短暂性尿失禁发生率方面显示出优势(P<0.05)。结论:经尿道前列腺棒状水囊扩裂术治疗良性前列腺增生疗效确切、操作简单、手术时间短、术中出血少、术后恢复快、并发症少且对性功能影响微弱,尤其适用于合并多种基础疾病、麻醉耐受性差、高龄BPH患者,宜于向基层临床推广。Objective:To investigate the clinical efficacy and safety of transurethral rod hydrosalping of the prostate in the treatment of benign prostatic hyperplasia.Methods:46 patients with prostatic hyperplasia admitted to our hospital from January 2019 to December 2020 were selected and randomly divided into observation group and control group with 23 patients in each group.The observation group was treated by transurethral prostatic rod hydrocolloid dilatation and the control group was treated by transurethral prostatic plasmaplasty.The patients in the observation group and the control group were recorded and compared in terms of pre-and post-operative observation indicators,recovery indicators and post-operative complications.Results:There was no significant difference in residual urine volume,maximum urinary flow rate,international prostate symptom IPSS score,and quality of life QoL score between the two groups at 3 months postoperative(P>0.05).Compared with the control group,the observation group featured advantages in operation time,intraoperative blood loss,postoperative extubation time,3 months postoperative sexual function(IIEF5)score,urethral stricture and the incidence of transient urinary incontinence,showing statistical significance(P<0.05).Conclusion:Transurethral prostatic hydrocele dilatation in the treatment of benign prostatic hyperplasia boasts a number of strengths as following:an exact curative effect,simple operation,short operation period,less intraoperative blood loss,quick postoperative recovery,less complications and weak influence on sexual function,it is especially suitable for patients with basic diseases,poor anesthesia tolerance,and elderly patients with BPH.Transurethral prostatic hydrocele dilatation in the treatment of benign prostatic hyperplasia is thus suitable for promotion to primary clinic.

关 键 词：棒状水囊 前列腺增生 疗效分析 

分 类 号：R697[医药卫生—泌尿科学]